•
Sep 30, 2019

Emergent BioSolutions Q3 2019 Earnings Report

Total Revenue
$312M
Previous year: $174M
+79.6%
EPS
$1.21
Previous year: $0.55
+120.0%
Adjusted EBITDA
$106M
Gross Profit
$204M
Previous year: $100M
+102.9%
Cash and Equivalents
$139M
Previous year: $339M
-59.0%
Free Cash Flow
-$18.4M
Previous year: $148M
-112.4%
Total Assets
$2.33B
Previous year: $1.17B
+98.9%

Emergent BioSolutions

Emergent BioSolutions